- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03562520
Toward Exercise as Medicine for Adolescents With Bipolar Disorder (TEAM-BD)
Toward Exercise as Medicine for Adolescents With Bipolar Disorder: A Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overarching goal of this project is to advance the field in terms of BCC approaches to improving AF among adolescents with BD, a group for whom improvements in AF offer multiple parallel benefits. This project will serve as a preliminary feasibility study, a necessary step in the path toward a well-powered, randomized controlled trial (RCT). If exercise is to achieve the same status as other evidence-based treatments for adolescents with BD, it will be necessary to evaluate exercise with the same level of rigor as other interventions. A crucial first step toward the ultimate goal of an adequately powered RCT is to demonstrate that adolescents with BD will enroll in, and actively participate in, an intervention study that accurately reflects what would be required of participants in such a study.
Objective 1: Evaluate the feasibility of developing a 24-week BCC intervention, customized and personalized for adolescents with BD, focusing on increasing AF.
Objective 2: Evaluate the feasibility of implementing the 24-week BCC intervention.
Objective 3: Evaluate the feasibility of measuring the effects of the intervention.
Exploratory: Examine the impact on AF of a 24-week BCC intervention, customized and personalized for adolescents with BD. Related hypothesis-generating analyses will examine the impact of specific variables (e.g., mood, medications, exercise-induced feelings, specific BCC modules, changes in motivation and self-efficacy) on AF changes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Sunnybrook Health Sciences Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English-speaking
- 13-21 years old
- Meet diagnostic criteria for BD (using KSADS-PL)
- Report moderate-vigorous exercise <150 minutes/week in the preceding 12 weeks
- Written clearance from primary care physician required
Exclusion Criteria:
- Unable to provide informed consent (e.g., severe psychosis, IQ<80)
- Presence of hypo/hypertension and history of exercise induced and aggravated conditions that are contraindications to proceeding with the study (e.g., syncope, asthma)
- Known cardiac condition (e.g., conduction abnormality, congenital heart disease) or other active medical condition that precludes aerobic exercise
- Known respiratory condition that precludes aerobic exercise
- Known health condition of physiological impairment that would preclude participation in exercise
- Currently manic (PSR score of 5 or 6 on mania)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adolescents with bipolar disorder
Forty adolescents (aged 13-21) with BD (type I, II, or not otherwise specified/other specified and related disorder) will be enrolled in the behavior change counseling intervention.
|
Core modules: 1 psychoeducation session at week 0; 4 behavior change counseling (BCC) sessions will occur at weeks 0, 4, 8, and 12; phone calls and/or texting sessions (weeks 1-3, 5-7, 9-11, and "booster" calls and/or texts on weeks 16 and 20) from therapists. Optional modules: Exercise coaching sessions; family involvement options will include participation in any aspect of the intervention; peer support options will include: group exercise classes on site, online Fitbit groups where adolescents can participate in competitions with each other and provide motivational support, and fitness support groups facilitated by registered social workers. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barriers to participation using the Client Satisfaction Questionnaire
Time Frame: Week 12
|
Week 12
|
|
Barriers to participation using the Client Satisfaction Questionnaire
Time Frame: Week 24
|
Week 24
|
|
Satisfaction of patient, parent, and consumer advocate co-investigators using the Client Satisfaction Questionnaire
Time Frame: Week 12
|
Week 12
|
|
Satisfaction of patient, parent, and consumer advocate co-investigators using the Client Satisfaction Questionnaire
Time Frame: Week 24
|
Week 24
|
|
Percentage of target sample size enrolled
Time Frame: three years (At the end of study completion)
|
three years (At the end of study completion)
|
|
Percentage of screened participants meeting inclusion criteria comparing number of participants screened to number of participants who meet inclusion criteria
Time Frame: Three years
|
Evaluating whether sample reflects clinical population in which exercise is an anticipated intervention
|
Three years
|
Barriers to recruitment
Time Frame: Three years
|
Qualitative assessment using phenomenological approach
|
Three years
|
Therapist adherence with behavior change counseling using the Behavior Change Counseling Index
Time Frame: three years
|
three years
|
|
Participant attendance
Time Frame: Week 0
|
Attendance at core sessions
|
Week 0
|
Participant attendance
Time Frame: Week 4
|
Attendance at core sessions
|
Week 4
|
Participant attendance
Time Frame: Week 8
|
Attendance at core sessions
|
Week 8
|
Participant attendance
Time Frame: Week 12
|
Attendance at core sessions
|
Week 12
|
Participant attendance
Time Frame: Week 1
|
Attendance at phone calls/texting sessions
|
Week 1
|
Participant attendance
Time Frame: Week 2
|
Attendance at phone calls/texting sessions
|
Week 2
|
Participant attendance
Time Frame: Week 3
|
Attendance at phone calls/texting sessions
|
Week 3
|
Participant attendance
Time Frame: Week 5
|
Attendance at phone calls/texting sessions
|
Week 5
|
Participant attendance
Time Frame: Week 6
|
Attendance at phone calls/texting sessions
|
Week 6
|
Participant attendance
Time Frame: Week 7
|
Attendance at phone calls/texting sessions
|
Week 7
|
Participant attendance
Time Frame: Week 9
|
Attendance at phone calls/texting sessions
|
Week 9
|
Participant attendance
Time Frame: Week 10
|
Attendance at phone calls/texting sessions
|
Week 10
|
Participant attendance
Time Frame: Week 11
|
Attendance at phone calls/texting sessions
|
Week 11
|
Participant attendance
Time Frame: Week 16
|
Attendance at phone calls/texting sessions
|
Week 16
|
Participant attendance
Time Frame: Week 20
|
Attendance at phone calls/texting sessions
|
Week 20
|
Participant completion of daily activity logs
Time Frame: three years
|
Number of daily activity logs completed for each participant
|
three years
|
Participant attendance
Time Frame: Week 1
|
Attendance at exercise coaching session
|
Week 1
|
Percentage of participants who selected the exercise coaching optional module
Time Frame: three years
|
three years
|
|
Percentage of participants who selected the family focused counseling optional module
Time Frame: three years
|
three years
|
|
Percentage of participants who selected the peer support optional module
Time Frame: three years
|
three years
|
|
Percentage of participants who completed the 24 weeks of the study
Time Frame: three years
|
three years
|
|
Percentage of participants who completed the 12 week intervention
Time Frame: three years
|
three years
|
|
Percentage of participants who completed all aerobic fitness testing sessions
Time Frame: three years
|
three years
|
|
Percentage of sessions attended by each team member
Time Frame: three years
|
three years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in aerobic fitness using the Modified Bruce Protocol
Time Frame: From week 0 to week 12
|
The modified Bruce Treadmill Test (weeks 0, 12) progresses through stages every 3 minutes, with each stage increasing in incline of the treadmill platform and increasing speed of treadmill belt.
The modified Bruce treadmill test will provide an estimation of VO2max based on treadmill time.
|
From week 0 to week 12
|
Change in aerobic fitness using the Modified Bruce Protocol
Time Frame: From week 12 to week 24
|
The modified Bruce Treadmill Test (weeks 12, 24) progresses through stages every 3 minutes, with each stage increasing in incline of the treadmill platform and increasing speed of treadmill belt.
The modified Bruce treadmill test will provide an estimation of VO2max based on treadmill time.
|
From week 12 to week 24
|
Change in aerobic fitness using the Modified Canadian Aerobic Fitness Test
Time Frame: From week 2 to week 8
|
The modified Canadian AF Test (weeks 2, 8), consists of stepping up and down two steps (20.3 cm in height each) during 3-minute stages while listening to set cadences.
The stepping rate will depend on age and sex, and participants will be required to reach a target heart rate of 85% of predicted maximum (220 - age).
VO2 max will be estimated through the following equation: VO2 max = 32.5 +13.6 x estimated oxygen cost (L/min) - 0.24 x age - 0.17 x weight (Kg).
|
From week 2 to week 8
|
Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Life Version (K-SADS-PL)
Time Frame: baseline
|
The K-SADS-PL is a semi-structured interview designed to ascertain present episode and lifetime history of psychiatric illness, according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria for children and adolescents.
|
baseline
|
Longitudinal Interval Follow-up Evaluation (LIFE)
Time Frame: baseline, week 12, week 24
|
The LIFE will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study
|
baseline, week 12, week 24
|
Brief Quality of Life in Bipolar Disorder (QoL.BD)
Time Frame: baseline, week 12, week 24
|
The Brief QoL.BD is a self-report that will be used to assess condition-specific quality of life.
Scale responses include: strongly disagree, disagree, neutral, agree, and strongly agree.
The scale assesses 12 basic domains of quality of life: physical, sleep, mood, cognition, leisure, social, spirituality, finances, household, self-esteem, independence, and identity.
Total scores can range from 12-60 with 60 identifying a high quality of life.
|
baseline, week 12, week 24
|
36-Item Short Form Health Survey (SF-36)
Time Frame: baseline, week 12, week 24
|
The SF-36 taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
It also includes a single item that provides an indication of perceived change in health.
To score, first, precoded numeric values are recoded per the scoring key given (see link).
Note that all items are scored so that a high score defines a more favorable health state.
In addition, each item is scored on a 0 to 100 range.
Scores represent the percentage of total possible score achieved.
In step 2, items in the same scale are averaged together to create the 8 scale scores.
Table 2 lists the items averaged together to create each scale.
Items that are left blank (missing data) are not taken into account when calculating.
https://www.rand.org/health/surveys_tools/mos/36-item-short-form/scoring.html
|
baseline, week 12, week 24
|
Client Satisfaction Questionnaire-8 (CSQ-8)
Time Frame: At weeks 12 and 24
|
The Client Satisfaction Questionnaire-8 will be used to assess intervention satisfaction.
An overall score is calculated by summing the respondent's rating (item rating) score for each scale item.
For the CSQ-8 version, scores therefore range from 8 to 32, with higher values indicating higher satisfaction.
Scoring values range from 1-4 with 4 meaning high satisfaction and 1 meaning low satisfaction.
|
At weeks 12 and 24
|
The Stages of Change Questionnaire (SCQ)
Time Frame: baseline, week 4, week 8, week 12, and week 24
|
The Stages of Change Questionnaire is a self-report that will provide the stage of behavior change relating to exercise status for discussion at BCC sessions.
Six statements are provided and the participant is asked to select the statement that best describes them.
This will then determine which stage of change they are in (precontemplation, contemplation, preparation, action, maintenance, or relapse).
|
baseline, week 4, week 8, week 12, and week 24
|
Outcome Expectations for Exercise (OEE)
Time Frame: baseline, week 12, week 24
|
The Outcome Expectations for Exercise tool will assess expectations of the benefits from physical activity.
The Outcome Expectations for Exercise Scale contains 9 statements rated by participants using a 5-point likert scale from 1 "Strongly Disagree" to 5 "Strongly Agree".
If negative or low expectations are found, an intervention can be implemented that may increase the expectancy of exercise and therefore create a more active lifestyle.
|
baseline, week 12, week 24
|
Motives for Physical Activities Measure-Revised (MPAM-R)
Time Frame: baseline, week 12, week 24
|
The MPAM-R will assess motives for activity participation.
There are five categories: interest/enjoyment, competence, appearance, fitness, and social.
It is rated on a likert scale ranging from 1 (not at all true for me) to 7 (very true for me).
|
baseline, week 12, week 24
|
Behavioral Regulation in Exercise Questionnaire (BREQ-3)
Time Frame: baseline, week 12, week 24
|
The Behavioral Regulation in Exercise Questionnaire-3 is a 24-item self-report scale that assesses the reasons why people exercise.
Questions range from 0 (not true for me) to 4 (very true for me).
BREQ has been used either as a multidimensional instrument giving separate scores for each subscale, or as a unidimensional index of the degree of self-determination, known as the relative autonomy index.
In order to use the BREQ as multidimensional scales, the mean scores are calculated for each set of items into categories (amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation).
|
baseline, week 12, week 24
|
Exercise Self-Efficacy
Time Frame: baseline, week 12, week 24
|
This measure will assess exercise-related self-efficacy.
An 11-point scale is used with 1 indicating "not at all confident" and 7 indicating "very confident".
Participants can also endorse 0 "does not apply to me".
High scores indicate high levels of self-efficacy.
|
baseline, week 12, week 24
|
Quick Weight, Activity, Variety, and Excess Screener (WAVE)
Time Frame: baseline, week 12, week 24
|
WAVE is a 17-item self-report instrument that ascertains 5 subscales: weight, physical activity, dietary variety, dietary excess, and household food insecurity.
The scores for each question can be added to generate an overall WAVE score that provides a quick estimate of the patient's overall health habits.
The WAVE score can range from 0 to 21.
The scores are interpreted as follows: 0 to 5= High priority for intervention to improve health habits; 6 to 11=In need of much improvement; 12 to 16=Some good health habits but needs improvement; and 17 to 21=Good to excellent health habits.
|
baseline, week 12, week 24
|
Drug Use Screening Inventory (DUSI)
Time Frame: baseline, week 12, week 24
|
Assesses drug use
|
baseline, week 12, week 24
|
Stressful Life Events Schedule (SLES)
Time Frame: baseline, week 12, week 24
|
The SLES (total score) ascertains 80 adolescent- and parent-reported negative life events, and their impact, during the preceding six months or time since last assessment.
Participants responds whether or not an event has occurred and then rate how much the event affected them on a scale of 1 to 4 (1=not at all to 4=a lot).
|
baseline, week 12, week 24
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: baseline, week 12, week 24
|
The PSQI is a self-rated questionnaire which assesses sleep quality and disturbances over a 1 month time interval.
Each question is scored with a total score of "5" or greater indicating poor sleep quality.
Items collect time and length of sleep.
Other items look at factors affecting sleep and responses range from 0 (not during the past month) to 3 (three or more times a week).
|
baseline, week 12, week 24
|
Exercise-Induced Feeling Inventory (EIFI)
Time Frame: baseline, then pre- and post-aerobic fitness testing at weeks 0, 2, 8, 12, and 24
|
The Exercise-Induced Feeling Inventory measures the intensity of 12 feeling states as they occur in relation to physical activity.
Responses are rated from 0 (do not feel) to 4 (feel very strongly) for each emotion.
The EIFI consists of 12 items that capture 4 distinct feeling states: revitalization, tranquility, positive engagement, and physical exhaustion.
The EIFI consists of 4 distinct subscales.
Subscale scores are obtained by summing or averaging the numerical values chosen for the adjectives within a particular subscale.
The four subscales include: (1) Positive Engagement (items 4, 7, & 12), (2) Revitalization (items, 1, 6, & 9), (3) Tranquility (items 2, 5, & 10), and (4) Physical Exhaustion (items, 3, 8, & 11).
|
baseline, then pre- and post-aerobic fitness testing at weeks 0, 2, 8, 12, and 24
|
Physical Activity Logs
Time Frame: Through study completion, an average of 24 weeks
|
The physical activity logs will be used by participants to record any moderate to vigorous intensity exercise, including details such as the time of day, type of exercise, and thoughts, feelings and physical sensations in regards to the exercise
|
Through study completion, an average of 24 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Benjamin I Goldstein, MD, PhD, Senior Scientist, Psychiatrist
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 007-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
University Hospital, Strasbourg, FranceUnknownBipolar Disorder I | Bipolar Disorder II | Rapid Cycling Bipolar Disorder(DSM-IV-TR)France
-
Universiteit AntwerpenUniversitair Ziekenhuis BrusselUnknownDepression | Mood Disorders | Bipolar Disorder | Bipolar Depression | Mental Disorder | Bipolar I Disorder | Bipolar II DisorderBelgium
Clinical Trials on Behavior change counseling
-
National Institute on Drug Abuse (NIDA)The Cooper Health SystemCompleted
-
Iowa State UniversityCompletedHypertension | AgingUnited States
-
The University of Texas Health Science Center at...CompletedHypertension | Diabetes Mellitus, Type 2 | HyperlipidemiaUnited States
-
Johns Hopkins UniversityCompletedChronic Low-back Pain | Patient ActivationUnited States
-
American Academy of Family PhysiciansRobert Wood Johnson Foundation; Agency for Healthcare Research and Quality...CompletedSmoking | Physical Activity | Diet | Alcohol AbuseUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)Completed
-
Chulalongkorn UniversityUnknown
-
Qazvin University Of Medical SciencesCompletedCoronary Artery Bypass Grafting (CABG) SurgeryIran, Islamic Republic of
-
Qazvin University Of Medical SciencesCompleted